PrepRARE Webinars: An Intro to Drug Development for Ataxias

The process for developing new treatments for any disease is long and complicated. This webinar will break down the process that every potential new therapy must go through from early lab testing through clinical trials and finally FDA approval before it is available to all affected individuals. Updates on progress towards effective therapies for multiple forms of genetic and sporadic ataxia will also be presented, along with information on how patients and their families can become partners in this process.

Speaker: Lauren Moore, PhD, Chief Scientific Officer, NAF

[Karlamack]

I wish there were medication or treatments to really help us.

[dipvsmou]

Hello.. Sir/Madam

I am DipNarayan Ghosh
My 2 years Son, Udit Narayan Ghosh is effected in OMAS . Opsoclonus Mayoclonus Ataxia Syandome disease. I am from The INDIA Country. Please help me for more care and all things to do with him . Please help me. ..., 🙏🙏